| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| EXAS - EXACT Sciences Corporation | BUY | 987 @ USD 101.9 | USD 100,575 | The ETF bought 987 new shares of EXAS (EXACT Sciences Corporation). The shares were bought for an average price of 101.9 compared to the previous average buy price of 62.0439. This is 64.2% higher than average price of previous purchases of EXAS. |
| ILMN - Illumina Inc | BUY | 731 @ USD 132.75 | USD 97,040 | The ETF bought 731 new shares of ILMN (Illumina Inc). The shares were bought for an average price of 132.75 compared to the previous average buy price of 95.299. This is 39.3% higher than average price of previous purchases of ILMN. |
| UCB.BR - UCB SA | BUY | 341 @ EUR 278.794 | EUR 95,069 | The ETF bought 341 new shares of UCB.BR (UCB SA). The shares were bought for an average price of 278.794 compared to the previous average buy price of 208.203. This is 33.9% higher than average price of previous purchases of UCB.BR. |
| IQV - IQVIA Holdings Inc | BUY | 403 @ USD 227.69 | USD 91,759 | The ETF bought 403 new shares of IQV (IQVIA Holdings Inc). The shares were bought for an average price of 227.69 compared to the previous average buy price of 162.435. This is 40.2% higher than average price of previous purchases of IQV. |
| TMO - Time Out Group plc | BUY | 155 @ USD 583.45 | USD 90,435 | The ETF bought 155 new shares of TMO (Time Out Group plc). The shares were bought for an average price of 583.45 compared to the previous average buy price of 418.499. This is 39.4% higher than average price of previous purchases of TMO. |
| GMAB.CO - | BUY | 281 @ DKK 319.155 | DKK 89,683 | The ETF bought 281 new shares of GMAB.CO (). The shares were bought for an average price of 319.155 compared to the previous average buy price of 222.447. This is 43.5% higher than average price of previous purchases of GMAB.CO. |
| NTRA - Natera Inc | BUY | 389 @ USD 229.98 | USD 89,462 | The ETF bought 389 new shares of NTRA (Natera Inc). The shares were bought for an average price of 229.98 compared to the previous average buy price of 176.324. This is 30.4% higher than average price of previous purchases of NTRA. |
| JNJ - Johnson & Johnson | BUY | 411 @ USD 206.91 | USD 85,040 | The ETF bought 411 new shares of JNJ (Johnson & Johnson). The shares were bought for an average price of 206.91 compared to the previous average buy price of 170.984. This is 21.0% higher than average price of previous purchases of JNJ. |
| MRK - Marks Electrical Group PLC | BUY | 791 @ USD 106.06 | USD 83,893 | The ETF bought 791 new shares of MRK (Marks Electrical Group PLC). The shares were bought for an average price of 106.06 compared to the previous average buy price of 80.8147. This is 31.2% higher than average price of previous purchases of MRK. |
| MRK - Merck & Company Inc | BUY | 791 @ USD 106.06 | USD 83,893 | The ETF bought 791 new shares of MRK (Merck & Company Inc). The shares were bought for an average price of 106.06 compared to the previous average buy price of 80.8147. This is 31.2% higher than average price of previous purchases of MRK. |
| BIIB - Biogen Inc | BUY | 475 @ USD 176.4 | USD 83,790 | The ETF bought 475 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 176.4 compared to the previous average buy price of 130.477. This is 35.2% higher than average price of previous purchases of BIIB. |
| ABBV - AbbVie Inc | BUY | 340 @ USD 229.74 | USD 78,112 | The ETF bought 340 new shares of ABBV (AbbVie Inc). The shares were bought for an average price of 229.74 compared to the previous average buy price of 201.245. This is 14.2% higher than average price of previous purchases of ABBV. |
| GSK.L - GlaxoSmithKline PLC | BUY | 3,161 @ GBP 24.6642 | GBP 77,964 | The ETF bought 3161 new shares of GSK.L (GlaxoSmithKline PLC). The shares were bought for an average price of 24.6642 compared to the previous average buy price of 19.3589. This is 27.4% higher than average price of previous purchases of GSK.L. |
| ROG.SW - | BUY | 187 @ CHF 414.944 | CHF 77,595 | The ETF bought 187 new shares of ROG.SW (). The shares were bought for an average price of 414.944 compared to the previous average buy price of 324.411. This is 27.9% higher than average price of previous purchases of ROG.SW. |
| NOVN.SW - | BUY | 543 @ CHF 138.568 | CHF 75,242 | The ETF bought 543 new shares of NOVN.SW (). The shares were bought for an average price of 138.568 compared to the previous average buy price of 113.545. This is 22.0% higher than average price of previous purchases of NOVN.SW. |
| HOLX - Hologic Inc | BUY | 989 @ USD 74.54 | USD 73,720 | The ETF bought 989 new shares of HOLX (Hologic Inc). The shares were bought for an average price of 74.54 compared to the previous average buy price of 66.2934. This is 12.4% higher than average price of previous purchases of HOLX. |
| A - Agilent Technologies Inc | BUY | 534 @ USD 137.62 | USD 73,489 | The ETF bought 534 new shares of A (Agilent Technologies Inc). The shares were bought for an average price of 137.62 compared to the previous average buy price of 122.269. This is 12.6% higher than average price of previous purchases of A. |
| DHR - Danaher Corporation | BUY | 318 @ USD 230.67 | USD 73,353 | The ETF bought 318 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 230.67 compared to the previous average buy price of 199.979. This is 15.3% higher than average price of previous purchases of DHR. |
| DHR - Danaher Corporation | BUY | 318 @ USD 230.67 | USD 73,353 | The ETF bought 318 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 230.67 compared to the previous average buy price of 199.979. This is 15.3% higher than average price of previous purchases of DHR. |
| EW - Edwards Lifesciences Corp | BUY | 850 @ USD 86.2 | USD 73,270 | The ETF bought 850 new shares of EW (Edwards Lifesciences Corp). The shares were bought for an average price of 86.2 compared to the previous average buy price of 74.591. This is 15.6% higher than average price of previous purchases of EW. |
| NBIX - Neurocrine Biosciences Inc | BUY | 516 @ USD 140.95 | USD 72,730 | The ETF bought 516 new shares of NBIX (Neurocrine Biosciences Inc). The shares were bought for an average price of 140.95 compared to the previous average buy price of 127.74. This is 10.3% higher than average price of previous purchases of NBIX. |
| GILD - Guild Esports Plc | BUY | 585 @ USD 123.18 | USD 72,060 | The ETF bought 585 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 123.18 compared to the previous average buy price of 107.342. This is 14.8% higher than average price of previous purchases of GILD. |
| AMGN - Amgen Inc | BUY | 219 @ USD 328.69 | USD 71,983 | The ETF bought 219 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 328.69 compared to the previous average buy price of 296.507. This is 10.9% higher than average price of previous purchases of AMGN. |
| MEDP - Medpace Holdings Inc | BUY | 125 @ USD 568.85 | USD 71,106 | The ETF bought 125 new shares of MEDP (Medpace Holdings Inc). The shares were bought for an average price of 568.85 compared to the previous average buy price of 382.527. This is 48.7% higher than average price of previous purchases of MEDP. |
| MDT - Medtronic PLC | BUY | 732 @ USD 96.66 | USD 70,755 | The ETF bought 732 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 96.66 compared to the previous average buy price of 90.2193. This is 7.1% higher than average price of previous purchases of MDT. |
| BMY - Bloomsbury Publishing Plc | BUY | 1,289 @ USD 54.21 | USD 69,877 | The ETF bought 1289 new shares of BMY (Bloomsbury Publishing Plc). The shares were bought for an average price of 54.21 compared to the previous average buy price of 53.3317. This is 1.6% higher than average price of previous purchases of BMY. |
| ISRG - Intuitive Surgical Inc | BUY | 121 @ USD 572.63 | USD 69,288 | The ETF bought 121 new shares of ISRG (Intuitive Surgical Inc). The shares were bought for an average price of 572.63 compared to the previous average buy price of 536.021. This is 6.8% higher than average price of previous purchases of ISRG. |
| 068270.KS - CELLTRION INC | BUY | 542 @ KRW 125.646 | KRW 68,100 | The ETF bought 542 new shares of 068270.KS (CELLTRION INC). The shares were bought for an average price of 125.646 compared to the previous average buy price of 121.694. This is 3.2% higher than average price of previous purchases of 068270.KS. |
| PFE - Pfizer Inc | BUY | 2,653 @ USD 24.99 | USD 66,298 | The ETF bought 2653 new shares of PFE (Pfizer Inc). The shares were bought for an average price of 24.99 compared to the previous average buy price of 24.3485. This is 2.6% higher than average price of previous purchases of PFE. |
| GH - Guardant Health Inc | BUY | 649 @ USD 100.6 | USD 65,289 | The ETF bought 649 new shares of GH (Guardant Health Inc). The shares were bought for an average price of 100.6 compared to the previous average buy price of 54.9629. This is 83.0% higher than average price of previous purchases of GH. |
| 207940.KS - SAMSUNG BIOLOGICS LTD | BUY | 55 @ KRW 1176.63 | KRW 64,715 | The ETF bought 55 new shares of 207940.KS (SAMSUNG BIOLOGICS LTD). The shares were bought for an average price of 1176.63 compared to the previous average buy price of 760.081. This is 54.8% higher than average price of previous purchases of 207940.KS. |
| EXEL - Exelixis Inc | BUY | 1,429 @ USD 44.04 | USD 62,933 | The ETF bought 1429 new shares of EXEL (Exelixis Inc). The shares were bought for an average price of 44.04 compared to the previous average buy price of 38.1215. This is 15.5% higher than average price of previous purchases of EXEL. |
| BSX - Boston Scientific Corporation | BUY | 649 @ USD 96.01 | USD 62,310 | The ETF bought 649 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 96.01 compared to the previous average buy price of 97.6281. This is -1.7% lower than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 649 @ USD 96.01 | USD 62,310 | The ETF bought 649 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 96.01 compared to the previous average buy price of 97.6281. This is -1.7% lower than average price of previous purchases of BSX. |
| LONN.SW - | BUY | 91 @ CHF 679.942 | CHF 61,875 | The ETF bought 91 new shares of LONN.SW (). The shares were bought for an average price of 679.942 compared to the previous average buy price of 640.611. This is 6.1% higher than average price of previous purchases of LONN.SW. |
| PODD - Insulet Corporation | BUY | 215 @ USD 287.03 | USD 61,711 | The ETF bought 215 new shares of PODD (Insulet Corporation). The shares were bought for an average price of 287.03 compared to the previous average buy price of 282.956. This is 1.4% higher than average price of previous purchases of PODD. |
| MRNA - Moderna Inc | BUY | 2,027 @ USD 30.41 | USD 61,641 | The ETF bought 2027 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 30.41 compared to the previous average buy price of 25.9653. This is 17.1% higher than average price of previous purchases of MRNA. |
| ABT - Abbott Laboratories | BUY | 480 @ USD 125.78 | USD 60,374 | The ETF bought 480 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 125.78 compared to the previous average buy price of 124.674. This is 0.9% higher than average price of previous purchases of ABT. |
| RVTY - Revvity Inc. | BUY | 618 @ USD 97.43 | USD 60,212 | The ETF bought 618 new shares of RVTY (Revvity Inc.). The shares were bought for an average price of 97.43 compared to the previous average buy price of 100.003. This is -2.6% lower than average price of previous purchases of RVTY. |
| CRL - Creightons Plc | BUY | 258 @ USD 201.98 | USD 52,111 | The ETF bought 258 new shares of CRL (Creightons Plc). The shares were bought for an average price of 201.98 compared to the previous average buy price of 165.907. This is 21.7% higher than average price of previous purchases of CRL. |
| DXCM - DexCom Inc | BUY | 761 @ USD 67.06 | USD 51,033 | The ETF bought 761 new shares of DXCM (DexCom Inc). The shares were bought for an average price of 67.06 compared to the previous average buy price of 78.8148. This is -14.9% lower than average price of previous purchases of DXCM. |
| TECH - Bio-Techne Corp | BUY | 823 @ USD 59.12 | USD 48,656 | The ETF bought 823 new shares of TECH (Bio-Techne Corp). The shares were bought for an average price of 59.12 compared to the previous average buy price of 59.3169. This is -0.3% lower than average price of previous purchases of TECH. |
| RGEN - Repligen Corporation | BUY | 275 @ USD 166.59 | USD 45,812 | The ETF bought 275 new shares of RGEN (Repligen Corporation). The shares were bought for an average price of 166.59 compared to the previous average buy price of 145.299. This is 14.7% higher than average price of previous purchases of RGEN. |
| 4523.T - Eisai Co., Ltd. | BUY | 1,500 @ JPY 29.8078 | JPY 44,712 | The ETF bought 1500 new shares of 4523.T (Eisai Co., Ltd.). The shares were bought for an average price of 29.8078 compared to the previous average buy price of 28.5269. This is 4.5% higher than average price of previous purchases of 4523.T. |
| PME.AX - | BUY | 295 @ AUD 149.354 | AUD 44,059 | The ETF bought 295 new shares of PME.AX (). The shares were bought for an average price of 149.354 compared to the previous average buy price of 165.183. This is -9.6% lower than average price of previous purchases of PME.AX. |
| HALO - Halozyme Therapeutics Inc | BUY | 647 @ USD 67.7 | USD 43,802 | The ETF bought 647 new shares of HALO (Halozyme Therapeutics Inc). The shares were bought for an average price of 67.7 compared to the previous average buy price of 60.3305. This is 12.2% higher than average price of previous purchases of HALO. |
| 7701.T - Shimadzu Corporation | BUY | 1,500 @ JPY 26.6607 | JPY 39,991 | The ETF bought 1500 new shares of 7701.T (Shimadzu Corporation). The shares were bought for an average price of 26.6607 compared to the previous average buy price of 26.4723. This is 0.7% higher than average price of previous purchases of 7701.T. |
| SRT3.DE - Sartorius AG | BUY | 132 @ EUR 290.67 | EUR 38,368 | The ETF bought 132 new shares of SRT3.DE (Sartorius AG). The shares were bought for an average price of 290.67 compared to the previous average buy price of 247.576. This is 17.4% higher than average price of previous purchases of SRT3.DE. |
| BIO - Bio-Rad Laboratories Inc | BUY | 112 @ USD 304.51 | USD 34,105 | The ETF bought 112 new shares of BIO (Bio-Rad Laboratories Inc). The shares were bought for an average price of 304.51 compared to the previous average buy price of 290.296. This is 4.9% higher than average price of previous purchases of BIO. |
| BIO - Biotest Aktiengesellschaft | BUY | 112 @ USD 304.51 | USD 34,105 | The ETF bought 112 new shares of BIO (Biotest Aktiengesellschaft). The shares were bought for an average price of 304.51 compared to the previous average buy price of 290.296. This is 4.9% higher than average price of previous purchases of BIO. |
| BIM.PA - BioMerieux | BUY | 256 @ EUR 129.461 | EUR 33,142 | The ETF bought 256 new shares of BIM.PA (BioMerieux). The shares were bought for an average price of 129.461 compared to the previous average buy price of 121.406. This is 6.6% higher than average price of previous purchases of BIM.PA. |
| RYTM - Rhythm Pharmaceuticals Inc | BUY | 304 @ USD 106.76 | USD 32,455 | The ETF bought 304 new shares of RYTM (Rhythm Pharmaceuticals Inc). The shares were bought for an average price of 106.76 compared to the previous average buy price of 67.8137. This is 57.4% higher than average price of previous purchases of RYTM. |
| PRAX - Praxis Precision Medicines Inc | BUY | 107 @ USD 297.02 | USD 31,781 | The ETF bought 107 new shares of PRAX (Praxis Precision Medicines Inc). The shares were bought for an average price of 297.02 compared to the previous average buy price of 167.342. This is 77.5% higher than average price of previous purchases of PRAX. |
| PTCT - PTC Therapeutics Inc | BUY | 415 @ USD 76.19 | USD 31,619 | The ETF bought 415 new shares of PTCT (PTC Therapeutics Inc). The shares were bought for an average price of 76.19 compared to the previous average buy price of 56.4444. This is 35.0% higher than average price of previous purchases of PTCT. |
| AXSM - Axsome Therapeutics Inc | BUY | 202 @ USD 148.79 | USD 30,056 | The ETF bought 202 new shares of AXSM (Axsome Therapeutics Inc). The shares were bought for an average price of 148.79 compared to the previous average buy price of 116.831. This is 27.4% higher than average price of previous purchases of AXSM. |
| IPN.PA - Ipsen SA | BUY | 191 @ EUR 139.926 | EUR 26,726 | The ETF bought 191 new shares of IPN.PA (Ipsen SA). The shares were bought for an average price of 139.926 compared to the previous average buy price of 120.641. This is 16.0% higher than average price of previous purchases of IPN.PA. |
| 6869.T - Sysmex Corporation | BUY | 2,700 @ JPY 9.86663 | JPY 26,640 | The ETF bought 2700 new shares of 6869.T (Sysmex Corporation). The shares were bought for an average price of 9.86663 compared to the previous average buy price of 14.9756. This is -34.1% lower than average price of previous purchases of 6869.T. |
| MMS - LYXETFETUSITETFP | BUY | 297 @ USD 86.91 | USD 25,812 | The ETF bought 297 new shares of MMS (LYXETFETUSITETFP). The shares were bought for an average price of 86.91 compared to the previous average buy price of 75.2803. This is 15.4% higher than average price of previous purchases of MMS. |
| 298380.KQ - ABL Bio Inc. | BUY | 183 @ KRW 138.836 | KRW 25,407 | The ETF bought 183 new shares of 298380.KQ (ABL Bio Inc.). The shares were bought for an average price of 138.836 compared to the previous average buy price of 40.1877. This is 245.5% higher than average price of previous purchases of 298380.KQ. |
| LNTH - Lantheus Holdings Inc | BUY | 366 @ USD 67.16 | USD 24,581 | The ETF bought 366 new shares of LNTH (Lantheus Holdings Inc). The shares were bought for an average price of 67.16 compared to the previous average buy price of 76.9588. This is -12.7% lower than average price of previous purchases of LNTH. |
| 7747.T - Asahi Intecc Co., Ltd. | BUY | 1,300 @ JPY 18.7898 | JPY 24,427 | The ETF bought 1300 new shares of 7747.T (Asahi Intecc Co., Ltd.). The shares were bought for an average price of 18.7898 compared to the previous average buy price of 16.8906. This is 11.2% higher than average price of previous purchases of 7747.T. |
| ALKS - Alkermes Plc | BUY | 871 @ USD 27.81 | USD 24,223 | The ETF bought 871 new shares of ALKS (Alkermes Plc). The shares were bought for an average price of 27.81 compared to the previous average buy price of 30.7179. This is -9.5% lower than average price of previous purchases of ALKS. |
| TGTX - TG Therapeutics Inc | BUY | 759 @ USD 29.75 | USD 22,580 | The ETF bought 759 new shares of TGTX (TG Therapeutics Inc). The shares were bought for an average price of 29.75 compared to the previous average buy price of 33.8235. This is -12.0% lower than average price of previous purchases of TGTX. |
| SECT-B.ST - | BUY | 778 @ SEK 27.2985 | SEK 21,238 | The ETF bought 778 new shares of SECT-B.ST (). The shares were bought for an average price of 27.2985 compared to the previous average buy price of 28.0136. This is -2.6% lower than average price of previous purchases of SECT-B.ST. |
| SFZN.SW - | BUY | 211 @ CHF 94.317 | CHF 19,901 | The ETF bought 211 new shares of SFZN.SW (). The shares were bought for an average price of 94.317 compared to the previous average buy price of 123.569. This is -23.7% lower than average price of previous purchases of SFZN.SW. |
| LGND - Ligand Pharmaceuticals Incorporated | BUY | 102 @ USD 190.2 | USD 19,400 | The ETF bought 102 new shares of LGND (Ligand Pharmaceuticals Incorporated). The shares were bought for an average price of 190.2 compared to the previous average buy price of 126.392. This is 50.5% higher than average price of previous purchases of LGND. |
| LIVN - LivaNova PLC | BUY | 285 @ USD 62.28 | USD 17,750 | The ETF bought 285 new shares of LIVN (LivaNova PLC). The shares were bought for an average price of 62.28 compared to the previous average buy price of 46.485. This is 34.0% higher than average price of previous purchases of LIVN. |
| ACAD - ACADIA Pharmaceuticals Inc | BUY | 661 @ USD 26.7 | USD 17,649 | The ETF bought 661 new shares of ACAD (ACADIA Pharmaceuticals Inc). The shares were bought for an average price of 26.7 compared to the previous average buy price of 20.1364. This is 32.6% higher than average price of previous purchases of ACAD. |
| VCYT - Veracyte Inc | BUY | 391 @ USD 42.28 | USD 16,531 | The ETF bought 391 new shares of VCYT (Veracyte Inc). The shares were bought for an average price of 42.28 compared to the previous average buy price of 34.3612. This is 23.0% higher than average price of previous purchases of VCYT. |
| IDYA - Ideaya Biosciences Inc | BUY | 469 @ USD 34.51 | USD 16,185 | The ETF bought 469 new shares of IDYA (Ideaya Biosciences Inc). The shares were bought for an average price of 34.51 compared to the previous average buy price of 23.8167. This is 44.9% higher than average price of previous purchases of IDYA. |
| CPRX - Catalyst Pharmaceuticals Inc | BUY | 656 @ USD 23.29 | USD 15,278 | The ETF bought 656 new shares of CPRX (Catalyst Pharmaceuticals Inc). The shares were bought for an average price of 23.29 compared to the previous average buy price of 22.4325. This is 3.8% higher than average price of previous purchases of CPRX. |
| BEAM - Beam Therapeutics Inc | BUY | 543 @ USD 27.82 | USD 15,106 | The ETF bought 543 new shares of BEAM (Beam Therapeutics Inc). The shares were bought for an average price of 27.82 compared to the previous average buy price of 18.6816. This is 48.9% higher than average price of previous purchases of BEAM. |
| SUPN - Supernus Pharmaceuticals Inc | BUY | 296 @ USD 49.89 | USD 14,767 | The ETF bought 296 new shares of SUPN (Supernus Pharmaceuticals Inc). The shares were bought for an average price of 49.89 compared to the previous average buy price of 36.2354. This is 37.7% higher than average price of previous purchases of SUPN. |
| ACLX - Arcellx Inc | BUY | 224 @ USD 63.6 | USD 14,246 | The ETF bought 224 new shares of ACLX (Arcellx Inc). The shares were bought for an average price of 63.6 compared to the previous average buy price of 64.8725. This is -2.0% lower than average price of previous purchases of ACLX. |
| VRDN - Viridian Therapeutics Inc | BUY | 445 @ USD 31.02 | USD 13,804 | The ETF bought 445 new shares of VRDN (Viridian Therapeutics Inc). The shares were bought for an average price of 31.02 compared to the previous average buy price of 30.1226. This is 3.0% higher than average price of previous purchases of VRDN. |
| ADPT - Adaptive Biotechnologies Corp | BUY | 812 @ USD 16.42 | USD 13,333 | The ETF bought 812 new shares of ADPT (Adaptive Biotechnologies Corp). The shares were bought for an average price of 16.42 compared to the previous average buy price of 6.89362. This is 138.2% higher than average price of previous purchases of ADPT. |
| CGON - CG Oncology, Inc. Common stock | BUY | 331 @ USD 40.17 | USD 13,296 | The ETF bought 331 new shares of CGON (CG Oncology, Inc. Common stock). The shares were bought for an average price of 40.17 compared to the previous average buy price of 41.6925. This is -3.7% lower than average price of previous purchases of CGON. |
| 326030.KS - SK BIOPHARMACEUTICALS LTD | BUY | 150 @ KRW 86.4948 | KRW 12,974 | The ETF bought 150 new shares of 326030.KS (SK BIOPHARMACEUTICALS LTD). The shares were bought for an average price of 86.4948 compared to the previous average buy price of 77.4592. This is 11.7% higher than average price of previous purchases of 326030.KS. |
| BAVA.CO - | BUY | 422 @ DKK 30.0497 | DKK 12,681 | The ETF bought 422 new shares of BAVA.CO (). The shares were bought for an average price of 30.0497 compared to the previous average buy price of 25.4205. This is 18.2% higher than average price of previous purchases of BAVA.CO. |
| BANB.SW - | BUY | 167 @ CHF 75.7317 | CHF 12,647 | The ETF bought 167 new shares of BANB.SW (). The shares were bought for an average price of 75.7317 compared to the previous average buy price of 65.0923. This is 16.3% higher than average price of previous purchases of BANB.SW. |
| EKTA-B.ST - | BUY | 1,995 @ SEK 6.17207 | SEK 12,313 | The ETF bought 1995 new shares of EKTA-B.ST (). The shares were bought for an average price of 6.17207 compared to the previous average buy price of 5.63298. This is 9.6% higher than average price of previous purchases of EKTA-B.ST. |
| NUVB - Nuvation Bio Inc | BUY | 1,303 @ USD 8.94 | USD 11,649 | The ETF bought 1303 new shares of NUVB (Nuvation Bio Inc). The shares were bought for an average price of 8.94 compared to the previous average buy price of 6.64051. This is 34.6% higher than average price of previous purchases of NUVB. |
| SRPT - Sarepta Therapeutics Inc | BUY | 537 @ USD 21.49 | USD 11,540 | The ETF bought 537 new shares of SRPT (Sarepta Therapeutics Inc). The shares were bought for an average price of 21.49 compared to the previous average buy price of 45.0034. This is -52.2% lower than average price of previous purchases of SRPT. |
| AUPH - Aurinia Pharmaceuticals Inc | BUY | 712 @ USD 15.82 | USD 11,264 | The ETF bought 712 new shares of AUPH (Aurinia Pharmaceuticals Inc). The shares were bought for an average price of 15.82 compared to the previous average buy price of 11.2153. This is 41.1% higher than average price of previous purchases of AUPH. |
| DIA.MI - DiaSorin SpA | BUY | 139 @ EUR 80.6868 | EUR 11,215 | The ETF bought 139 new shares of DIA.MI (DiaSorin SpA). The shares were bought for an average price of 80.6868 compared to the previous average buy price of 54.1257. This is 49.1% higher than average price of previous purchases of DIA.MI. |
| TECN.SW - | BUY | 68 @ CHF 162.463 | CHF 11,047 | The ETF bought 68 new shares of TECN.SW (). The shares were bought for an average price of 162.463 compared to the previous average buy price of 197.12. This is -17.6% lower than average price of previous purchases of TECN.SW. |
| CRVL - CorVel Corp | BUY | 159 @ USD 68.26 | USD 10,853 | The ETF bought 159 new shares of CRVL (CorVel Corp). The shares were bought for an average price of 68.26 compared to the previous average buy price of 111.522. This is -38.8% lower than average price of previous purchases of CRVL. |
| ATRC - AtriCure Inc | BUY | 265 @ USD 40.18 | USD 10,648 | The ETF bought 265 new shares of ATRC (AtriCure Inc). The shares were bought for an average price of 40.18 compared to the previous average buy price of 33.402. This is 20.3% higher than average price of previous purchases of ATRC. |
| QDEL - Quidel Corporation | BUY | 359 @ USD 29.3 | USD 10,519 | The ETF bought 359 new shares of QDEL (Quidel Corporation). The shares were bought for an average price of 29.3 compared to the previous average buy price of 29.52. This is -0.7% lower than average price of previous purchases of QDEL. |
| CHEMM.CO - | BUY | 94 @ DKK 108.248 | DKK 10,175 | The ETF bought 94 new shares of CHEMM.CO (). The shares were bought for an average price of 108.248 compared to the previous average buy price of 78.2284. This is 38.4% higher than average price of previous purchases of CHEMM.CO. |
| HLUN-B.CO - | BUY | 1,456 @ DKK 6.79562 | DKK 9,894 | The ETF bought 1456 new shares of HLUN-B.CO (). The shares were bought for an average price of 6.79562 compared to the previous average buy price of 6.0023. This is 13.2% higher than average price of previous purchases of HLUN-B.CO. |
| DVAX - Dynavax Technologies Corporation | BUY | 638 @ USD 15.37 | USD 9,806 | The ETF bought 638 new shares of DVAX (Dynavax Technologies Corporation). The shares were bought for an average price of 15.37 compared to the previous average buy price of 12.6313. This is 21.7% higher than average price of previous purchases of DVAX. |
| TWST - Twist Bioscience Corp | BUY | 304 @ USD 32.15 | USD 9,774 | The ETF bought 304 new shares of TWST (Twist Bioscience Corp). The shares were bought for an average price of 32.15 compared to the previous average buy price of 36.2456. This is -11.3% lower than average price of previous purchases of TWST. |
| 6951.T - JEOL Ltd. | BUY | 300 @ JPY 32.1809 | JPY 9,654 | The ETF bought 300 new shares of 6951.T (JEOL Ltd.). The shares were bought for an average price of 32.1809 compared to the previous average buy price of 33.0489. This is -2.6% lower than average price of previous purchases of 6951.T. |
| TXG - 10X Genomics Inc | BUY | 590 @ USD 16.29 | USD 9,611 | The ETF bought 590 new shares of TXG (10X Genomics Inc). The shares were bought for an average price of 16.29 compared to the previous average buy price of 12.5355. This is 30.0% higher than average price of previous purchases of TXG. |
| TXG - Terex Corporation | BUY | 590 @ USD 16.29 | USD 9,611 | The ETF bought 590 new shares of TXG (Terex Corporation). The shares were bought for an average price of 16.29 compared to the previous average buy price of 12.5355. This is 30.0% higher than average price of previous purchases of TXG. |
| KNSA - Kiniksa Pharmaceuticals Ltd | BUY | 234 @ USD 40.99 | USD 9,592 | The ETF bought 234 new shares of KNSA (Kiniksa Pharmaceuticals Ltd). The shares were bought for an average price of 40.99 compared to the previous average buy price of 40.3374. This is 1.6% higher than average price of previous purchases of KNSA. |
| 9995.HK - REMEGEN LTD H | BUY | 1,000 @ HKD 9.34868 | HKD 9,349 | The ETF bought 1000 new shares of 9995.HK (REMEGEN LTD H). The shares were bought for an average price of 9.34868 compared to the previous average buy price of 9.70899. This is -3.7% lower than average price of previous purchases of 9995.HK. |
| STOK - Stoke Therapeutics Inc | BUY | 291 @ USD 31.82 | USD 9,260 | The ETF bought 291 new shares of STOK (Stoke Therapeutics Inc). The shares were bought for an average price of 31.82 compared to the previous average buy price of 12.0607. This is 163.8% higher than average price of previous purchases of STOK. |
| RCUS - Arcus Biosciences Inc | BUY | 397 @ USD 23.23 | USD 9,222 | The ETF bought 397 new shares of RCUS (Arcus Biosciences Inc). The shares were bought for an average price of 23.23 compared to the previous average buy price of 9.14068. This is 154.1% higher than average price of previous purchases of RCUS. |
| HRMY - Harmony Biosciences Holdings | BUY | 238 @ USD 37.64 | USD 8,958 | The ETF bought 238 new shares of HRMY (Harmony Biosciences Holdings). The shares were bought for an average price of 37.64 compared to the previous average buy price of 32.6637. This is 15.2% higher than average price of previous purchases of HRMY. |
| 3933.HK - THE UNITED LABORATORIES INTERNATIO | BUY | 6,000 @ HKD 1.49065 | HKD 8,944 | The ETF bought 6000 new shares of 3933.HK (THE UNITED LABORATORIES INTERNATIO). The shares were bought for an average price of 1.49065 compared to the previous average buy price of 1.67688. This is -11.1% lower than average price of previous purchases of 3933.HK. |
| BCRX - BioCryst Pharmaceuticals Inc | BUY | 1,164 @ USD 7.66 | USD 8,916 | The ETF bought 1164 new shares of BCRX (BioCryst Pharmaceuticals Inc). The shares were bought for an average price of 7.66 compared to the previous average buy price of 7.74854. This is -1.1% lower than average price of previous purchases of BCRX. |
| NEU.AX - | BUY | 706 @ AUD 12.6036 | AUD 8,898 | The ETF bought 706 new shares of NEU.AX (). The shares were bought for an average price of 12.6036 compared to the previous average buy price of 8.87049. This is 42.1% higher than average price of previous purchases of NEU.AX. |
| RXRX - Recursion Pharmaceuticals Inc | BUY | 2,131 @ USD 4.11 | USD 8,758 | The ETF bought 2131 new shares of RXRX (Recursion Pharmaceuticals Inc). The shares were bought for an average price of 4.11 compared to the previous average buy price of 5.14428. This is -20.1% lower than average price of previous purchases of RXRX. |
| FTRE - Fortrea Holdings Inc. | BUY | 501 @ USD 17.38 | USD 8,707 | The ETF bought 501 new shares of FTRE (Fortrea Holdings Inc.). The shares were bought for an average price of 17.38 compared to the previous average buy price of 10.5322. This is 65.0% higher than average price of previous purchases of FTRE. |
| TNDM - Tandem Diabetes Care Inc | BUY | 373 @ USD 22.51 | USD 8,396 | The ETF bought 373 new shares of TNDM (Tandem Diabetes Care Inc). The shares were bought for an average price of 22.51 compared to the previous average buy price of 21.1386. This is 6.5% higher than average price of previous purchases of TNDM. |
| NEOG - Neogen Corporation | BUY | 1,168 @ USD 7.05 | USD 8,234 | The ETF bought 1168 new shares of NEOG (Neogen Corporation). The shares were bought for an average price of 7.05 compared to the previous average buy price of 9.99438. This is -29.5% lower than average price of previous purchases of NEOG. |
| 13.HK - HUTCHMED (CHINA) LTD | BUY | 3,000 @ HKD 2.62919 | HKD 7,888 | The ETF bought 3000 new shares of 13.HK (HUTCHMED (CHINA) LTD). The shares were bought for an average price of 2.62919 compared to the previous average buy price of 3.01399. This is -12.8% lower than average price of previous purchases of 13.HK. |
| AXGN - Axogen Inc | BUY | 239 @ USD 32.73 | USD 7,822 | The ETF bought 239 new shares of AXGN (Axogen Inc). The shares were bought for an average price of 32.73 compared to the previous average buy price of 18.047. This is 81.4% higher than average price of previous purchases of AXGN. |
| NVCR - Novocure Ltd | BUY | 573 @ USD 13.22 | USD 7,575 | The ETF bought 573 new shares of NVCR (Novocure Ltd). The shares were bought for an average price of 13.22 compared to the previous average buy price of 16.4121. This is -19.4% lower than average price of previous purchases of NVCR. |
| 4887.T - Sawai Group Holdings Co., Ltd. | BUY | 500 @ JPY 15.0894 | JPY 7,545 | The ETF bought 500 new shares of 4887.T (Sawai Group Holdings Co., Ltd.). The shares were bought for an average price of 15.0894 compared to the previous average buy price of 13.195. This is 14.4% higher than average price of previous purchases of 4887.T. |
| BIOA-B.ST - | BUY | 223 @ SEK 33.8023 | SEK 7,538 | The ETF bought 223 new shares of BIOA-B.ST (). The shares were bought for an average price of 33.8023 compared to the previous average buy price of 29.997. This is 12.7% higher than average price of previous purchases of BIOA-B.ST. |
| ZYME - Zymeworks Inc. Common Stock | BUY | 278 @ USD 26.54 | USD 7,378 | The ETF bought 278 new shares of ZYME (Zymeworks Inc. Common Stock). The shares were bought for an average price of 26.54 compared to the previous average buy price of 17.6935. This is 50.0% higher than average price of previous purchases of ZYME. |
| 2162.HK - KEYMED BIOSCIENCES INC | BUY | 1,000 @ HKD 6.86212 | HKD 6,862 | The ETF bought 1000 new shares of 2162.HK (KEYMED BIOSCIENCES INC). The shares were bought for an average price of 6.86212 compared to the previous average buy price of 5.35965. This is 28.0% higher than average price of previous purchases of 2162.HK. |
| 2252.HK - SHANGHAI MICROPORT MEDBOT CLASS H | BUY | 2,000 @ HKD 3.42078 | HKD 6,842 | The ETF bought 2000 new shares of 2252.HK (SHANGHAI MICROPORT MEDBOT CLASS H). The shares were bought for an average price of 3.42078 compared to the previous average buy price of 3.16268. This is 8.2% higher than average price of previous purchases of 2252.HK. |
| GLPG.AS - Galapagos NV | BUY | 207 @ EUR 32.6651 | EUR 6,762 | The ETF bought 207 new shares of GLPG.AS (Galapagos NV). The shares were bought for an average price of 32.6651 compared to the previous average buy price of 29.0814. This is 12.3% higher than average price of previous purchases of GLPG.AS. |
| PHM.MC - Pharma Mar SA | BUY | 74 @ EUR 87.7772 | EUR 6,496 | The ETF bought 74 new shares of PHM.MC (Pharma Mar SA). The shares were bought for an average price of 87.7772 compared to the previous average buy price of 87.1976. This is 0.7% higher than average price of previous purchases of PHM.MC. |
| RLAY - Relay Therapeutics Inc | BUY | 773 @ USD 8.35 | USD 6,455 | The ETF bought 773 new shares of RLAY (Relay Therapeutics Inc). The shares were bought for an average price of 8.35 compared to the previous average buy price of 5.08308. This is 64.3% higher than average price of previous purchases of RLAY. |
| PHARM.AS - Pharming Group NV | BUY | 3,831 @ EUR 1.67559 | EUR 6,419 | The ETF bought 3831 new shares of PHARM.AS (Pharming Group NV). The shares were bought for an average price of 1.67559 compared to the previous average buy price of 0.896789. This is 86.8% higher than average price of previous purchases of PHARM.AS. |
| BLFS - BioLife Solutions Inc | BUY | 257 @ USD 24.66 | USD 6,338 | The ETF bought 257 new shares of BLFS (BioLife Solutions Inc). The shares were bought for an average price of 24.66 compared to the previous average buy price of 25.7305. This is -4.2% lower than average price of previous purchases of BLFS. |
| CSTL - Castle Biosciences Inc | BUY | 159 @ USD 39.31 | USD 6,250 | The ETF bought 159 new shares of CSTL (Castle Biosciences Inc). The shares were bought for an average price of 39.31 compared to the previous average buy price of 21.3129. This is 84.4% higher than average price of previous purchases of CSTL. |
| DYVOX.ST - | BUY | 562 @ SEK 11.0934 | SEK 6,234 | The ETF bought 562 new shares of DYVOX.ST (). The shares were bought for an average price of 11.0934 compared to the previous average buy price of 6.29712. This is 76.2% higher than average price of previous purchases of DYVOX.ST. |
| 039200.KQ - Oscotec Inc. | BUY | 185 @ KRW 31.3769 | KRW 5,805 | The ETF bought 185 new shares of 039200.KQ (Oscotec Inc.). The shares were bought for an average price of 31.3769 compared to the previous average buy price of 21.0043. This is 49.4% higher than average price of previous purchases of 039200.KQ. |
| ANAB - AnaptysBio Inc | BUY | 119 @ USD 48.23 | USD 5,739 | The ETF bought 119 new shares of ANAB (AnaptysBio Inc). The shares were bought for an average price of 48.23 compared to the previous average buy price of 23.8129. This is 102.5% higher than average price of previous purchases of ANAB. |
| CERT - Certara Inc | BUY | 646 @ USD 8.86 | USD 5,724 | The ETF bought 646 new shares of CERT (Certara Inc). The shares were bought for an average price of 8.86 compared to the previous average buy price of 10.4074. This is -14.9% lower than average price of previous purchases of CERT. |
| SDGR - Schrodinger Inc | BUY | 320 @ USD 17.8 | USD 5,696 | The ETF bought 320 new shares of SDGR (Schrodinger Inc). The shares were bought for an average price of 17.8 compared to the previous average buy price of 22.5384. This is -21.0% lower than average price of previous purchases of SDGR. |
| 237690.KQ - ST Pharm Co.,Ltd. | BUY | 68 @ KRW 82.7462 | KRW 5,627 | The ETF bought 68 new shares of 237690.KQ (ST Pharm Co.,Ltd.). The shares were bought for an average price of 82.7462 compared to the previous average buy price of 55.5458. This is 49.0% higher than average price of previous purchases of 237690.KQ. |
| NVAX - Novavax Inc | BUY | 835 @ USD 6.72 | USD 5,611 | The ETF bought 835 new shares of NVAX (Novavax Inc). The shares were bought for an average price of 6.72 compared to the previous average buy price of 6.53102. This is 2.9% higher than average price of previous purchases of NVAX. |
| NVAX - Hana Microelectronics Public Company Limited | BUY | 835 @ USD 6.72 | USD 5,611 | The ETF bought 835 new shares of NVAX (Hana Microelectronics Public Company Limited). The shares were bought for an average price of 6.72 compared to the previous average buy price of 6.53102. This is 2.9% higher than average price of previous purchases of NVAX. |
| ASTH - Astrana Health Inc | BUY | 224 @ USD 24.97 | USD 5,593 | The ETF bought 224 new shares of ASTH (Astrana Health Inc). The shares were bought for an average price of 24.97 compared to the previous average buy price of 26.5685. This is -6.0% lower than average price of previous purchases of ASTH. |
| ONT.L - Oxford Nanopore Technologies Ltd | BUY | 3,188 @ GBP 1.72602 | GBP 5,503 | The ETF bought 3188 new shares of ONT.L (Oxford Nanopore Technologies Ltd). The shares were bought for an average price of 1.72602 compared to the previous average buy price of 1.72772. This is -0.1% lower than average price of previous purchases of ONT.L. |
| CDNA - Caredx Inc | BUY | 285 @ USD 19.07 | USD 5,435 | The ETF bought 285 new shares of CDNA (Caredx Inc). The shares were bought for an average price of 19.07 compared to the previous average buy price of 19.212. This is -0.7% lower than average price of previous purchases of CDNA. |
| EVT.DE - Evotec SE | BUY | 835 @ EUR 6.40838 | EUR 5,351 | The ETF bought 835 new shares of EVT.DE (Evotec SE). The shares were bought for an average price of 6.40838 compared to the previous average buy price of 6.56761. This is -2.4% lower than average price of previous purchases of EVT.DE. |
| 4587.T - PeptiDream Inc. | BUY | 500 @ JPY 10.5958 | JPY 5,298 | The ETF bought 500 new shares of 4587.T (PeptiDream Inc.). The shares were bought for an average price of 10.5958 compared to the previous average buy price of 11.127. This is -4.8% lower than average price of previous purchases of 4587.T. |
| AMLX - Amylyx Pharmaceuticals Inc | BUY | 412 @ USD 12 | USD 4,944 | The ETF bought 412 new shares of AMLX (Amylyx Pharmaceuticals Inc). The shares were bought for an average price of 12 compared to the previous average buy price of 13.5196. This is -11.2% lower than average price of previous purchases of AMLX. |
| 302440.KS - SK BIOSCIENCE LTD | BUY | 145 @ KRW 33.4594 | KRW 4,852 | The ETF bought 145 new shares of 302440.KS (SK BIOSCIENCE LTD). The shares were bought for an average price of 33.4594 compared to the previous average buy price of 36.2275. This is -7.6% lower than average price of previous purchases of 302440.KS. |
| IART - Integra LifeSciences Holdings | BUY | 377 @ USD 12.68 | USD 4,780 | The ETF bought 377 new shares of IART (Integra LifeSciences Holdings). The shares were bought for an average price of 12.68 compared to the previous average buy price of 20.1099. This is -36.9% lower than average price of previous purchases of IART. |
| ARVN - Arvinas Inc | BUY | 395 @ USD 11.73 | USD 4,633 | The ETF bought 395 new shares of ARVN (Arvinas Inc). The shares were bought for an average price of 11.73 compared to the previous average buy price of 11.3626. This is 3.2% higher than average price of previous purchases of ARVN. |
| KURA - Kura Oncology Inc | BUY | 439 @ USD 10.22 | USD 4,487 | The ETF bought 439 new shares of KURA (Kura Oncology Inc). The shares were bought for an average price of 10.22 compared to the previous average buy price of 10.711. This is -4.6% lower than average price of previous purchases of KURA. |
| 007390.KQ - NatureCell Co.,Ltd. | BUY | 296 @ KRW 15.1331 | KRW 4,479 | The ETF bought 296 new shares of 007390.KQ (NatureCell Co.,Ltd.). The shares were bought for an average price of 15.1331 compared to the previous average buy price of 21.4176. This is -29.3% lower than average price of previous purchases of 007390.KQ. |
| JANX - Janux Therapeutics Inc | BUY | 323 @ USD 13.83 | USD 4,467 | The ETF bought 323 new shares of JANX (Janux Therapeutics Inc). The shares were bought for an average price of 13.83 compared to the previous average buy price of 24.7281. This is -44.1% lower than average price of previous purchases of JANX. |
| ABCL - Abcellera Biologics Inc | BUY | 1,292 @ USD 3.45 | USD 4,457 | The ETF bought 1292 new shares of ABCL (Abcellera Biologics Inc). The shares were bought for an average price of 3.45 compared to the previous average buy price of 3.61385. This is -4.5% lower than average price of previous purchases of ABCL. |
| EUZ.DE - Eckert & Ziegler SE | BUY | 244 @ EUR 17.9435 | EUR 4,378 | The ETF bought 244 new shares of EUZ.DE (Eckert & Ziegler SE). The shares were bought for an average price of 17.9435 compared to the previous average buy price of 18.7965. This is -4.5% lower than average price of previous purchases of EUZ.DE. |
| IOVA - Iovance Biotherapeutics Inc | BUY | 1,566 @ USD 2.77 | USD 4,338 | The ETF bought 1566 new shares of IOVA (Iovance Biotherapeutics Inc). The shares were bought for an average price of 2.77 compared to the previous average buy price of 2.41138. This is 14.9% higher than average price of previous purchases of IOVA. |
| 328130.KQ - Lunit Inc. | BUY | 150 @ KRW 28.5308 | KRW 4,280 | The ETF bought 150 new shares of 328130.KQ (Lunit Inc.). The shares were bought for an average price of 28.5308 compared to the previous average buy price of 36.3011. This is -21.4% lower than average price of previous purchases of 328130.KQ. |
| DAWN - Day One Biopharmaceuticals Inc | BUY | 433 @ USD 9.18 | USD 3,975 | The ETF bought 433 new shares of DAWN (Day One Biopharmaceuticals Inc). The shares were bought for an average price of 9.18 compared to the previous average buy price of 8.3429. This is 10.0% higher than average price of previous purchases of DAWN. |
| EMBC - Embecta Corp | BUY | 328 @ USD 12.07 | USD 3,959 | The ETF bought 328 new shares of EMBC (Embecta Corp). The shares were bought for an average price of 12.07 compared to the previous average buy price of 13.0183. This is -7.3% lower than average price of previous purchases of EMBC. |
| CTKB - Cytek Biosciences Inc | BUY | 751 @ USD 5.04 | USD 3,785 | The ETF bought 751 new shares of CTKB (Cytek Biosciences Inc). The shares were bought for an average price of 5.04 compared to the previous average buy price of 5.7145. This is -11.8% lower than average price of previous purchases of CTKB. |
| RGNX - Regenxbio Inc | BUY | 254 @ USD 14.09 | USD 3,579 | The ETF bought 254 new shares of RGNX (Regenxbio Inc). The shares were bought for an average price of 14.09 compared to the previous average buy price of 8.67354. This is 62.4% higher than average price of previous purchases of RGNX. |
| VLA.PA - Valneva SE | BUY | 783 @ EUR 4.38592 | EUR 3,434 | The ETF bought 783 new shares of VLA.PA (Valneva SE). The shares were bought for an average price of 4.38592 compared to the previous average buy price of 2.91512. This is 50.5% higher than average price of previous purchases of VLA.PA. |
| 096530.KQ - Seegene, Inc. | BUY | 206 @ KRW 16.5215 | KRW 3,403 | The ETF bought 206 new shares of 096530.KQ (Seegene, Inc.). The shares were bought for an average price of 16.5215 compared to the previous average buy price of 17.6933. This is -6.6% lower than average price of previous purchases of 096530.KQ. |
| VIR - Vir Biotechnology Inc | BUY | 581 @ USD 5.84 | USD 3,393 | The ETF bought 581 new shares of VIR (Vir Biotechnology Inc). The shares were bought for an average price of 5.84 compared to the previous average buy price of 7.32775. This is -20.3% lower than average price of previous purchases of VIR. |
| VIR - Vidrala S.A | BUY | 581 @ USD 5.84 | USD 3,393 | The ETF bought 581 new shares of VIR (Vidrala S.A). The shares were bought for an average price of 5.84 compared to the previous average buy price of 7.32775. This is -20.3% lower than average price of previous purchases of VIR. |
| RO.SW - | BUY | 8 @ CHF 423.794 | CHF 3,390 | The ETF bought 8 new shares of RO.SW (). The shares were bought for an average price of 423.794 compared to the previous average buy price of 370.354. This is 14.4% higher than average price of previous purchases of RO.SW. |
| MYGN - Myriad Genetics Inc | BUY | 520 @ USD 6.17 | USD 3,208 | The ETF bought 520 new shares of MYGN (Myriad Genetics Inc). The shares were bought for an average price of 6.17 compared to the previous average buy price of 8.64702. This is -28.6% lower than average price of previous purchases of MYGN. |
| 7575.T - Japan Lifeline Co., Ltd. | BUY | 300 @ JPY 10.0809 | JPY 3,024 | The ETF bought 300 new shares of 7575.T (Japan Lifeline Co., Ltd.). The shares were bought for an average price of 10.0809 compared to the previous average buy price of 10.1423. This is -0.6% lower than average price of previous purchases of 7575.T. |
| PACB - Pacific Biosciences of California | BUY | 1,726 @ USD 1.73 | USD 2,986 | The ETF bought 1726 new shares of PACB (Pacific Biosciences of California). The shares were bought for an average price of 1.73 compared to the previous average buy price of 1.37661. This is 25.7% higher than average price of previous purchases of PACB. |
| XVIVO.ST - | BUY | 140 @ SEK 20.2944 | SEK 2,841 | The ETF bought 140 new shares of XVIVO.ST (). The shares were bought for an average price of 20.2944 compared to the previous average buy price of 40.1806. This is -49.5% lower than average price of previous purchases of XVIVO.ST. |
| IBRX - Immunitybio Inc | BUY | 1,313 @ USD 1.98 | USD 2,600 | The ETF bought 1313 new shares of IBRX (Immunitybio Inc). The shares were bought for an average price of 1.98 compared to the previous average buy price of 2.81966. This is -29.8% lower than average price of previous purchases of IBRX. |
| LAB - Standard Biotools Inc | BUY | 1,981 @ USD 1.25 | USD 2,476 | The ETF bought 1981 new shares of LAB (Standard Biotools Inc). The shares were bought for an average price of 1.25 compared to the previous average buy price of 1.39779. This is -10.6% lower than average price of previous purchases of LAB. |
| EVH - Evolent Health Inc | BUY | 606 @ USD 4.05 | USD 2,454 | The ETF bought 606 new shares of EVH (Evolent Health Inc). The shares were bought for an average price of 4.05 compared to the previous average buy price of 9.55347. This is -57.6% lower than average price of previous purchases of EVH. |
| MRVI - Maravai Lifesciences Holdings Inc | BUY | 745 @ USD 3.27 | USD 2,436 | The ETF bought 745 new shares of MRVI (Maravai Lifesciences Holdings Inc). The shares were bought for an average price of 3.27 compared to the previous average buy price of 2.97559. This is 9.9% higher than average price of previous purchases of MRVI. |
| VNDA - Vanda Pharmaceuticals Inc | BUY | 321 @ USD 7.03001 | USD 2,257 | The ETF bought 321 new shares of VNDA (Vanda Pharmaceuticals Inc). The shares were bought for an average price of 7.03001 compared to the previous average buy price of 4.65578. This is 51.0% higher than average price of previous purchases of VNDA. |
| 1877.HK - SHANGHAI JUNSHI BIOSCIENCES LTD H | BUY | 800 @ HKD 2.77312 | HKD 2,218 | The ETF bought 800 new shares of 1877.HK (SHANGHAI JUNSHI BIOSCIENCES LTD H). The shares were bought for an average price of 2.77312 compared to the previous average buy price of 2.51798. This is 10.1% higher than average price of previous purchases of 1877.HK. |
| SLP - Sylvania Platinum Limited | BUY | 85 @ USD 18.22 | USD 1,549 | The ETF bought 85 new shares of SLP (Sylvania Platinum Limited). The shares were bought for an average price of 18.22 compared to the previous average buy price of 26.1345. This is -30.3% lower than average price of previous purchases of SLP. |
| 4549.T - Eiken Chemical Co., Ltd. | BUY | 100 @ JPY 15.3964 | JPY 1,540 | The ETF bought 100 new shares of 4549.T (Eiken Chemical Co., Ltd.). The shares were bought for an average price of 15.3964 compared to the previous average buy price of 13.728. This is 12.2% higher than average price of previous purchases of 4549.T. |
| 4974.T - Takara Bio Inc. | BUY | 200 @ JPY 5.08523 | JPY 1,017 | The ETF bought 200 new shares of 4974.T (Takara Bio Inc.). The shares were bought for an average price of 5.08523 compared to the previous average buy price of 5.75157. This is -11.6% lower than average price of previous purchases of 4974.T. |
| ARCT - Arcturus Therapeutics Holdings Inc | BUY | 124 @ USD 6.18999 | USD 768 | The ETF bought 124 new shares of ARCT (Arcturus Therapeutics Holdings Inc). The shares were bought for an average price of 6.18999 compared to the previous average buy price of 13.0207. This is -52.5% lower than average price of previous purchases of ARCT. |
| - - | HOLD | 0 @ USD 0 | USD 0 | The current share valuation price of - based on adjusted close was USD 0. The average price that - shares were previous bought at was USD 0.00279608. The current market price is -100.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of however if the holding was sold on 2025-12-30 this would crystalise an overall loss. |
| 182400.KQ - NKMAX LTD | HOLD | 0 @ KRW 3.99639 | KRW 0 | |